Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2023-12-19 Regulatory Filings
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 19, 2023, by uniQure N.V. It provides updates on ongoing clinical trials and announces an investor call and webcast. The content includes interim clinical trial data, safety and tolerability information, and forward-looking statements. There are no full financial statements or comprehensive financial performance data typical of annual or quarterly reports. The document is a current report disclosing material events and updates, consistent with the purpose of an 8-K filing. It is not a full annual report (10-K), interim report (IR), earnings release (ER), or other detailed financial report. The document is a regulatory filing reporting material events and disclosures as required by the SEC. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-12-19 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by uniQure N.V. on December 8, 2023. Form S-8 is used to register securities to be offered to employees under employee benefit plans, specifically inducement equity awards in this case. The document includes detailed information about the equity awards, incorporation by reference of other filings (10-K, 10-Q, 8-K), and legal and procedural statements related to the registration. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2023-12-08 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 15, 2023, reporting on the results of an Extraordinary General Meeting of shareholders. It details the approval of amendments to the company's 2014 Share Incentive Plan and the voting results of the proposals. The document includes descriptions of the plan amendments, voting outcomes, and references to a definitive proxy statement filed earlier. The content focuses on shareholder voting results and changes related to share incentive plans, which aligns with announcements of voting results rather than the proxy solicitation materials themselves. The document is not a full annual or quarterly report, nor is it a management discussion or earnings release. It is not a certification or legal proceeding report. Given the detailed voting results and shareholder meeting outcomes, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6332 characters) and content confirm it is a substantive report of voting results, not merely an announcement of a report publication or a proxy solicitation. Therefore, the classification is DVA with high confidence.
2023-11-17 English
10-Q
Interim / Quarterly Report Q3 2023
2023-11-07 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 7, 2023, by uniQure N.V. It announces the issuance of a press release reporting financial results for the quarter ended September 30, 2023. The document itself does not contain the financial results but rather furnishes the press release as an exhibit. The text explicitly states that the information is furnished and not filed, and it is a current report announcing quarterly financial results. Given the short length (3869 characters) and the nature of the document as an announcement of financial results rather than the full report, this fits the definition of an Earnings Release (ER).
2023-11-07 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-10-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.